Published Date: 02 Mar 2023
Members of Congress are scrambling to test whether Bayh-Dole's "walk-in" provisions for patents on federally-funded discoveries could lower the cost of certain drugs in the United States.
Read Full News1.
Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.
2.
Medical Journal March 29, 2023
3.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
4.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
5.
The lack of psychiatrists may be addressed by community workers.
1.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
2.
Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health
3.
Community-Based Cancer Survivorship Support Systems
4.
Case-Based Learning on Clonal Hematopoiesis With Unexpected Clinical Progression
5.
Radiation Oncology Advances: Guidelines, Trials, Digital Tools & Education
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XI
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation